Janux Therapeutics
JANX • NASDAQ
Janux Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Alan Campbell, with a market cap of $940.5M.
Market Cap$940.5M
Employees68.0
CEODavid Alan Campbell
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Janux Therapeutics FAQ
Common questions about Janux Therapeutics
Janux Therapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $3.8M.
Janux Therapeutics has approximately 68 employees.